報名方式：線上報名。受限於場地限制，限額140名，額滿為止。

教育學分：中華民國血液病學會甲類4分、中華民國血液及骨髓移植學會1分、中華民國癌症醫學會腫瘤內科Ａ類3學分、中華民國癌症醫學會腫瘤外科Ａ類3學分、台灣兒科醫學會1分、台灣癌症安寧緩和醫學會B類1分。

Time	Topic	Faculty
14:00–14:05	Welcome and Introduction	Chairman: Dr. Kai-Hsin Lin
14:05–14:10	Recognizing and managing NTDT	Moderator of session: Dr. Chang-Fang Chiu
14:10–14:15	E-voting
14:15–14:30	Diagnosis: a step-by-step approach	Dr. J. B. Porter, England
14:30–14:35	Q & A
14:35–14:50	Transfusion therapy: advantages & disadvantages	Dr. V. Viprakasit, Bangkok
14:50–14:55	Q & A
14:55–15:35	Panel discussion I:   Complications in HbH patients and their management Clinical case: HbH complication	Moderator: Dr. Chang-Fang Chiu International faculty Presenters: Dr. V. Viprakasit, Bangkok Dr. Bor-Sheng Ko
15:35–15:55	Break
15:55–16:00	Iron overload and NTDT	Moderator of session: Dr. Cheng-Shyong Chang
16:00–16:05	E-voting
16:05–16:20	Detection and monitoring of iron overload	Dr. Meng-Yao Lu
16:20–16:25	Q & A
16:25–16:45	Overview on iron chelation therapy and NTDT	Dr. J. B. Porter, England
16:45–16:50	Q & A
16:50–16:55	Iron chelation therapy for TDT: what have we learned?	Moderator of session: Dr. Shyh-Shin Chiou
16:55–17:00	E-voting
17:00–17:30	Personalizing treatment by liver and cardiac iron profile (5 clinical cases)	Dr. J. B. Porter, England
17:30–17:40	Q & A
17:40–18:20	Panel discussion II     How to manage the apparent non-responders Clinical case	Moderator Dr. Shyh-Shin Chiou International faculty Presenters: Dr. V. Viprakasit, Bangkok Dr. Hsiu-Hao Chang
18:20–18:25	Closing Remarks	Dr. Jih-Luh Tang